The EGShares Financials GEMS (NYSEArca:FGEM), a fund that
invests in large emerging market companies in the financials
industry, was No. 1 on IndexUniverse's "Bottom 10 1-Day Performers"
list, with 5.15 percent in losses.
GEMS was one of a number of emerging market funds that fell on
Friday, as investors have become concerned about a bubble in
developing countries fueled in part by overstretched European
The db-X MSCI Brazil Currency-Hedged Equity (NYSEArca:DBBR) was
No. 5 on the list, with 3.31 percent in losses. The Market Vectors
China (NYSEArca:PEK) was No. 9 on the list, with 2.84 percent in
The PowerShares KBW Capital Markets Portfolio (NYSEArca:KBWC), a
fund that holds broker-dealers, asset managers, trust and custody
banks, was No. 2 on the bottom-performers list, with 4.55 percent
in losses-a victim perhaps of increased worries about the
implications of JP Morgan's trading losses last week.
Agriculture-related commodity ETFs also were hit hard on Friday,
spurred by concerns about slowing global growth.
The iPath Dow Jones-UBS Cotton Total Return ETN (NYSEArca:BAL)
was No. 3 on the bottom performers list, returning 3.57 percent in
The C-Tracks Exchange-Traded Notes on the Citi Volatility
(NYSEArca:CVOL) was No. 1 on IndexUniverse's "Top 10 1-Day
Performers" list-one of a number of volatility-related funds that
benefitted from investor conerns about the stability of the
eurozone and the implications of JP Morgan's trading loss.
The iPath S&P 500 VIX Mid-Term Futures ETN (NYSEArca:VXZ)
was No. 4 on the top performers, list with 1.71 percent in
The iPath S&P VIX Short-Term Futures ETN (NYSEArca:VXX) was
No. 6 on the list, with 1.57 percent in gains. The VelocityShares
VIX Short Term ETN (NYSEArca:VIIX) was No. 8 on the list, with 1.42
percent in gains.
Biotech ETFs also surged on Friday, in part due to last week's
announcement by Vertex Pharmaceuticals of a study showing positive
results for a new treatment for cystic fibrosis.
The SPDR S&P Biotech ETF (NYSEArca:XBI) was No. 3 on the top
performers list, with 1.75 percent in gains.
Also, the Market Vectors Biotech ETF (NYSEArca:BBH) was No. 9 on
the list, with 1.34 percent in gains. The iShares Nasdaq
Biotechnology Index Fund (NYSEArca:IBB) was No. 10 on the list,
with 1.33 percent in gains.
Top 10 1-Day Performers, Excluding Leverage/Inverse Funds and
'lt;1,000 Shares Traded
Bottom 10 1-Day Performers, Excluding Leverage/Inverse
Funds and 'lt;1,000 Shares Traded
||AUM ($, mm)
||C-Tracks Exchange-Traded Notes on the Citi
||iShares MSCI Emerging Markets EMEA Index
||SPDR S&P Biotech
||iPath S&P 500 VIX Mid-Term Futures ETN
||PIMCO 25+ Year Zero Coupon U.S. Treasury
||iPath S&P 500 VIX Short-Term Futures ETN
||ProShares VIX Mid-term
||VelocityShares VIX Short Term ETN
||Market Vectors Biotech
||iShares NASDAQ Biotechnology
||AUM ($, mm)
||EGShares Financials GEMS
||PowerShares KBW Capital Markets Portfolio
||iPath Dow Jones-UBS Cotton Total Return ETN
||db-X MSCI Brazil Currency-Hedged Equity
||Market Vectors Vietnam
||PowerShares DB Agriculture Long ETN
||Global X PURE Gold Miners
||Market Vectors China
||Global X Gold Explorers
Disclaimer:All data as of 6 a.m. Eastern time the date the
article is published. Data is believed to be accurate; however,
transient market data is often subject to subsequent revision and
correction by the exchanges.
Permalink | 'copy; Copyright 2009 IndexUniverse LLC. All rights
Don't forget to check IndexUniverse.com's ETF Data
2012 IndexUniverse LLC
. All Rights Reserved.